Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)

 

The purpose of the Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) is to support a single multi-component basic collaborative Research Program to conduct hypothesis-driven studies of trauma induced coagulopathy (TIC). Through this initiative, the National Heart, Lung and Blood Institute (NHLBI) and the Department of Defense (DoD) are in partnership to form a consortium with the UM1 Research Program to address TIC research. The TACTIC program will link clinical investigators involved with ongoing DoD funded trauma-related clinical trials with the UM1 Research Program scientists who will have the unique opportunity to utilize patient samples in their basic research in TIC.

Deleted 03/09/2013 (Archived.) RFA-HL-13-025 Agency: Department of Health and Human Services
Office: National Institutes of Health Cooperative Agreement 1 Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. 02/06/2013 This program does not have cost sharing or matching requirements. NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-025.html FBOWebmaster@OD.NIH.GOV $24,000,000.00 Awards up to $4,800,000.00